The composition of advisory committees at the U.S. Food and Drug Administration (FDA) raises questions about the impartiality of drug evaluations. A recent review...
Mineralys Therapeutics, Inc. (Nasdaq: MLYS) is progressing towards filing a new drug application (NDA) for its leading drug candidate, lorundrostat, following a series of...